Evaluation of non-ATP competitive PI3K# inhibition with IOA-244 in the treatment of lymphoma
People
(Responsible)
Additional information
Start date
01.08.2021
End date
01.08.2023
Duration
24 Months
Funding sources
Status
Ended
Category
Innosuisse /
Innovation projects
